BRW 📈 Saba Capital Income & - Overview
Exchange: NYSE • Country: USA • Currency: USD • Type: Fund • ISIN: US92913A1007 • Bank Loan
BRW: Bonds, Loans, Credit, Securities, Investments
Additional Sources for BRW Fund
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BRW Fund Overview
Market Cap in USD | 367m |
Style | Bank Loan |
TER | 2.31% |
IPO / Inception | 1988-05-12 |
BRW Fund Ratings
Growth 5y | 55.4% |
Fundamental | - |
Dividend | 92.4% |
Rel. Strength Industry | 304 |
Analysts | - |
Fair Price Momentum | 8.36 USD |
Fair Price DCF | - |
BRW Dividends
Dividend Yield 12m | 12.10% |
Yield on Cost 5y | 15.64% |
Annual Growth 5y | 13.45% |
Payout Consistency | 91.9% |
BRW Growth Ratios
Growth Correlation 3m | 93.5% |
Growth Correlation 12m | 83% |
Growth Correlation 5y | 86.6% |
CAGR 5y | 5.27% |
CAGR/Mean DD 5y | 0.91 |
Sharpe Ratio 12m | 0.85 |
Alpha | -1.52 |
Beta | 0.49 |
Volatility | 14.13% |
Current Volume | 149.5k |
Average Volume 20d | 213.6k |
What is the price of BRW stocks?
As of December 21, 2024, the stock is trading at USD 7.73 with a total of 149,500 shares traded.
Over the past week, the price has changed by -1.15%, over one month by +3.07%, over three months by +8.00% and over the past year by +15.61%.
As of December 21, 2024, the stock is trading at USD 7.73 with a total of 149,500 shares traded.
Over the past week, the price has changed by -1.15%, over one month by +3.07%, over three months by +8.00% and over the past year by +15.61%.
Is Saba Capital Income & a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Saba Capital Income & (NYSE:BRW) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 55.41 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BRW as of December 2024 is 8.36. This means that BRW is currently overvalued and has a potential downside of 8.15%.
Partly, yes. Based on ValueRay Analyses, Saba Capital Income & (NYSE:BRW) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 55.41 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BRW as of December 2024 is 8.36. This means that BRW is currently overvalued and has a potential downside of 8.15%.
Is BRW a buy, sell or hold?
Saba Capital Income & has no consensus analysts rating.
Saba Capital Income & has no consensus analysts rating.
What are the forecast for BRW stock price target?
According to ValueRays Forecast Model, BRW Saba Capital Income & will be worth about 9.2 in December 2025. The stock is currently trading at 7.73. This means that the stock has a potential upside of +18.37%.
According to ValueRays Forecast Model, BRW Saba Capital Income & will be worth about 9.2 in December 2025. The stock is currently trading at 7.73. This means that the stock has a potential upside of +18.37%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 9.2 | 18.4% |